ST Pharm Co.,Ltd. (KOSDAQ: 237690)

ST Pharm Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	40,979	50,097	50,201	39,203	38,625	12,823
Short-Term Investments	33,594	40,000	-	44,000	84,001	38,170
Trading Asset Securities	26,392	-	-	10,013	18,011	14,046
Cash & Short-Term Investments	100,965	90,097	50,201	93,216	140,636	65,039
Cash Growth	-2.54%	79.47%	-46.15%	-33.72%	116.24%	-39.62%
Accounts Receivable	50,455	120,566	94,210	62,949	45,435	35,425
Other Receivables	-	1,500	3,131	1,499	1,236	273.02
Receivables	50,455	122,066	97,341	64,448	46,671	35,698
Inventory	158,624	120,736	107,623	80,809	45,401	40,925
Prepaid Expenses	9,996	11,901	5,818	5,039	1,798	117.53
Other Current Assets	3,442	3,577	2,251	628.76	1,107	2,372
Total Current Assets	323,482	348,378	263,234	244,142	235,613	144,152
Property, Plant & Equipment	310,098	280,105	257,885	210,190	175,634	170,980
Long-Term Investments	8,033	10,728	11,492	13,264	7,756	3,006
Goodwill	-	9,950	8,947	8,455	8,044	7,791
Other Intangible Assets	16,231	3,513	3,532	4,164	1,952	1,310
Long-Term Deferred Tax Assets	8,134	7,498	17,127	15,732	14,699	12,674
Other Long-Term Assets	25,615	15,264	8,436	2,619	1,872	695.9
Total Assets	691,593	675,436	570,652	498,565	445,570	340,610
Accounts Payable	8,874	17,661	18,095	12,865	4,694	7,164
Accrued Expenses	-	8,264	9,365	6,558	3,097	2,216
Short-Term Debt	30,000	20,878	105,854	-	-	-
Current Portion of Long-Term Debt	8,333	8,333	8,293	15,000	-	19.5
Current Portion of Leases	1,267	1,039	1,185	587.24	894.1	423.65
Current Income Taxes Payable	57.86	4,430	2,377	1,322	-	-
Other Current Liabilities	32,405	23,139	34,054	16,243	9,925	6,404
Total Current Liabilities	80,937	83,745	179,224	52,575	18,610	16,227
Long-Term Debt	80,259	159,689	16,707	91,451	125,646	15,078
Long-Term Leases	1,721	2,143	2,481	479.1	386.54	472.78
Long-Term Unearned Revenue	-	-	-	956.3	1,698	1,808
Other Long-Term Liabilities	38,483	42,369	31,138	27,071	2,451	2,239
Total Liabilities	203,069	288,530	229,549	172,533	148,817	37,401
Common Stock	10,054	9,404	9,404	9,404	9,328	9,328
Additional Paid-In Capital	313,657	225,940	195,747	195,714	174,919	168,725
Retained Earnings	148,212	135,729	126,893	115,590	111,634	123,561
Comprehensive Income & Other	16,193	13,476	5,587	2,266	-552.72	-791.7
Total Common Equity	488,116	384,550	337,632	322,974	295,328	300,822
Minority Interest	407.96	2,356	3,471	3,058	1,425	2,387
Shareholders' Equity	488,524	386,906	341,103	326,033	296,753	303,209
Total Liabilities & Equity	691,593	675,436	570,652	498,565	445,570	340,610
Total Debt	121,581	192,082	134,521	107,517	126,927	15,994
Net Cash (Debt)	-20,616	-101,984	-84,320	-14,301	13,709	49,045
Net Cash Growth	-	-	-	-	-72.05%	-54.42%
Net Cash Per Share	-1075.66	-5422.17	-4483.00	-766.21	734.85	2628.89
Filing Date Shares Outstanding	20.11	18.81	18.81	18.81	18.66	18.66
Total Common Shares Outstanding	20.11	18.81	18.81	18.81	18.66	18.66
Working Capital	242,545	264,634	84,010	191,567	217,003	127,925
Book Value Per Share	24275.09	20445.26	17950.76	17171.46	15830.19	16124.69
Tangible Book Value	471,885	371,088	325,153	310,355	285,333	291,721
Tangible Book Value Per Share	23467.87	19729.50	17287.30	16500.56	15294.42	15636.85
Land	-	60,024	59,999	52,910	52,908	52,895
Buildings	-	146,984	118,168	102,362	103,273	101,985
Machinery	-	195,642	157,855	120,141	115,304	108,829
Construction In Progress	-	20,794	44,421	50,144	12,071	2,731

Source: S&P Capital IQ. Standard template. Financial Sources.